Table 3.
Univariable HR (95% CI) | p | Adjusted HRa (95% CI) | p | |
---|---|---|---|---|
Age, years | 0.97 (0.90–1.05) | 0.5 | 0.93 (0.83–1.04) | 0.2 |
Hemodialysis vintage, months | 0.99 (0.98–1.01) | 0.8 | 1.00 (0.97–1.02) | 0.7 |
Obesity, yes | 0.56 (0.11–2.82) | 0.4 | 1.38 (0.25–7.58) | 0.7 |
Current smoker, yes | 0.13 (0.02–0.84) | 0.03 | 4.48 (0.54–36.92) | 0.1 |
Diabetes mellitus, yes | 3.55 (0.41–30.41) | 0.2 | 0.63 (0.06–6.76) | 0.7 |
Coronary heart disease, yes | 0.33 (0.03–2.97) | 0.3 | 0.98 (0.05–17.54) | 0.9 |
Charlson comorbidity index | 1.08 (0.76–1.53) | 0.6 | 0.84 (0.51–1.40) | 0.5 |
Basal oxygen saturation, % | 0.82 (0.71–0.94) | <0.01 | 0.79 (0.66–0.94) | <0.01 |
Hemoglobin, g/L | 0.51 (0.32–0.83) | <0.01 | 0.49 (0.26–0.94) | 0.03 |
Lymphocytes, 109/L | 0.46 (0.11–1.87) | 0.2 | 0.49 (0.17–1.43) | 0.1 |
C–reactive protein, mg/L | 1.00 (0.99–1.01) | 0.5 | 1.01 (0.99–1.02) | 0.1 |
Serum albumin, g/dL | 0.21 (0.05–0.82) | 0.02 | 0.13 (0.02–0.82) | 0.03 |
LDH, U/L | 1.00 (0.99–1.00) | 0.8 | 1.00 (0.99–1.00) | 0.4 |
Lopinavir–ritonavir, yes | 0.13 (0.02–0.76) | 0.02 | 2.79 (0.41–18.87) | 0.2 |
Tocilizumab, yes | 0.11 (0.02–0.56) | <0.01 | 4.22 (0.73–24.42) | 0.1 |
Hydroxychloroquine, yes | 1.15 (0.18–7.11) | 0.8 | 26.7 (1.15–61.9) | 0.04 |
Glucocorticoids, yes | 0.07 (0.00–0.63) | 0.01 | 4.29 (0.29–62.67) | 0.2 |
HR: hazard ratio; LDH: lactate dehydrogenase.
Age and basal oxygen saturation.